Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure.

Abstract

PURPOSE We investigated the risk factors and management of pleural effusion associated with dasatinib therapy for chronic myelogenous leukemia (CML) after failure of imatinib. PATIENTS AND METHODS We analyzed 138 patients with CML treated with dasatinib from November 2003 to January 2006 in one phase I (n = 50) and four phase II (n = 88) studies for the… (More)

Topics

Cite this paper

@article{QuintsCardama2007PleuralEI, title={Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure.}, author={Alfonso Quint{\'a}s-Cardama and Hagop M. Kantarjian and Susan M O'Brien and Gautham Borthakur and John Bruzzi and Reginald F. Munden and Jorge Cort{\'e}s}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2007}, volume={25 25}, pages={3908-14} }